Evrysdi is approved in 70 countries and submitted in a further 31 with more than 4,500 patients treated to date
APS03118 is a novel innovative drug developed by APS with global independent intellectual property rights for unlimited cancer types
First launches expected in H1 2022
It is the first monoclonal antibody drug for use in any animal species
The new collaboration focuses on a class of proteins called transcription factors, which control gene expression and can regulate important cellular processes including cell growth and survival
This advanced technology for Diabetic Foot Ulcer (DFU), management has a high scope of preventing amputations in diabetic patients. It has no definitive treatment in India. This technology will be available at affordable rates
First Positive Study for KEYTRUDA in Adjuvant Stage IB-IIIA NSCLC
Natco Pharma has received approval for Covid 19 drug molnupiravir capsules 200 mg. for Indian market, which will be sold under brand name Molnunat
Autism spectrum disorder affects 78 million people and families worldwide
Prucalopride medicine in the form of Orally Disintegrating Strips are most convenient dosage form for geriatric patients
Subscribe To Our Newsletter & Stay Updated
